http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0618500-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d829f463baf07a56b9778d3ded43b798 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b789c9ee6e99f691af463ffdeee73cda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb5c6fac6141fc26d66fd4dcf3ff19a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545c4967837e53a72277d5cbf8775cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bbc772532db2ce3a17bf7abeb60e459 |
| publicationDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0618500-A2 |
| titleOfInvention | use of a biologically active material, pharmaceutical composition and biologically active agent |
| abstract | USE OF A BIOLOGICALLY ACTIVE MATERIAL, PHARMACEUTICAL COMPOSITION AND BIOLOGICALLY ACTIVE AGENT. The present invention relates to agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, hepatic liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are described: where n is 1 or 2; one of m and x is O and the other is 0.1, 2, 3, or 4; q is 0 or 1; t is o or 1; R 2 is alkyl having 1 to 3 carbon atoms; R3 is hydrogen, halo, alkyl having 1 to 3 carbon atoms, or alkoxy having 1 to 3 carbon atoms; one of R ^ 4 ^ and R ^ 5 ^ is alkyl having 1 to 3 carbon atoms and the other is hydrogen or alkyl having 1 to 3 carbon atoms; A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or cycloalkyl having 3 to 6 ring carbon atoms in which cycloalkyl is unsubstituted or one or two ring carbons are independently monosubstituted by methyl or ethyl; or a 5- or 6-membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently linked to the residue of the compound of formula 1 by a ring carbon; and R ^ 1 ^ ou is hydrogen or alkyl having 1 or 2 carbon atoms. Alternatively, when R ^ 1 ^ ^ is hydrogen, the biologically active agent can be a pharmaceutically acceptable salt of the compound of formula I. |
| priorityDate | 2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 256.